The low-risk category may be variably-defined but would always include a group of patients with Gleason less than 7, stage T2 or less and PSA less than 10 [10]; this group represents the overwhelming majority of men with incident prostate cancer [14]. This evidence concerns the gene KLK3 and Familial prostate cancer.